Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Precision Biosciences (DTIL) Leases (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Leases for 6 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 16.98% to $6.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.1 million, a 16.98% decrease, with the full-year FY2024 number at $7.1 million, down 14.2% from a year prior.
  • Leases was $6.1 million for Q3 2025 at Precision Biosciences, down from $6.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $8.3 million in Q4 2023 to a low of $1.1 million in Q3 2023.
  • A 5-year average of $5.3 million and a median of $5.8 million in 2021 define the central range for Leases.
  • Peak YoY movement for Leases: tumbled 67.28% in 2023, then soared 587.08% in 2024.
  • Precision Biosciences' Leases stood at $4.2 million in 2021, then crashed by 53.01% to $2.0 million in 2022, then soared by 320.72% to $8.3 million in 2023, then dropped by 14.2% to $7.1 million in 2024, then decreased by 13.43% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Leases are $6.1 million (Q3 2025), $6.5 million (Q2 2025), and $6.8 million (Q1 2025).